Showing results (2231-2240 of 2,503) with videos related to

Sort By:
Pageof 251
European Journal of Cancer (Oxford, England : 1990)|March 18, 2020
Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019Selma Ugurel, Joachim Röhmel, Paolo A Ascierto, et al.
Cancer Research|April 17, 2019
HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor TherapyMichael F Emmons, Fernanda Faião-Flores, Ritin Sharma, et al.
American Heart Journal|April 30, 2017
Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromesGregory Ducrocq, Phillip J Schulte, Andrzej Budaj, et al.
The British Journal of Dermatology|July 27, 2025
Avelumab plus cetuximab in patients with unresectable stage III or IV cutaneous squamous cell carcinoma - clinical activity and safety results from AliCe, a single-arm, multicentre phase 2 DeCOG trialJürgen C Becker, Anja H Gesierich, Ulrike Leiter, et al.
JMIR Research Protocols|March 20, 2024
Efficacy of Integrating the Management of Pain and Addiction via Collaborative Treatment (IMPACT) in Individuals With Chronic Pain and Opioid Use Disorder: Protocol for a Randomized Clinical Trial of a Digital Cognitive Behavioral TreatmentR Ross MacLean, Brett Ankawi, Mary A Driscoll, et al.
Journal of the American Heart Association|May 23, 2024
Assessment of Days Alive Out of Hospital as a Possible End Point in Trials of Stroke Prevention for Atrial Fibrillation: A ROCKET AF AnalysisJosephine Harrington, Anne S Hellkamp, Kenneth W Mahaffey, et al.
American Heart Journal|June 4, 2018
Safety of ticagrelor in patients with baseline conduction abnormalities: A PLATO (Study of Platelet Inhibition and Patient Outcomes) analysisBenjamin M Scirica, Sameer Bansilal, Farideh Davoudi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trialF Egberts, R Gutzmer, S Ugurel, et al.
Clinical Cardiology|February 2, 2018
Efficacy and safety of rivaroxaban compared with warfarin in patients with carotid artery disease and nonvalvular atrial fibrillation: Insights from the ROCKET AF trialAjar Kochar, Anne S Hellkamp, Yuliya Lokhnygina, et al.
International Journal of Cardiology|November 18, 2008
Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey, Simon T Tonev, Sarah A Spinler, et al.
Pageof 251